Pharmacies - Japan

Japan

The Pharmacies market in Japan is expected to experience significant growth in the coming years.
It is projected that by 2024, the market's revenue will reach a staggering ¥€77.51bn.
This growth is anticipated to continue with an annual growth rate of 1.58% from 2024 to 2029, resulting in a market volume of ¥€83.85bn by the end of this period.
When compared to other countries, United States is expected to generate the highest revenue in the Pharmacies market, reaching a remarkable ¥€355.40bn in 2024.
This highlights the dominance of the US in this industry.
In terms of per person revenues, the Pharmacies market is predicted to generate ¥€632.10 per individual in Japan in 2024.
This figure reflects the revenue generated by the market in relation to the total population of the country.
The Japanese pharmaceutical market is experiencing a shift towards online pharmacies, driven by the convenience and accessibility they offer to consumers in a technologically advanced society.

Key regions: United States, China, Germany, Japan, Europe

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Pharmacies market in Japan has been experiencing steady growth in recent years, driven by several key factors. Customer preferences for convenience and accessibility, along with the country's unique local special circumstances, have contributed to the development of this market. Additionally, underlying macroeconomic factors have played a significant role in shaping the trends observed in the Pharmacies market in Japan. Customer preferences in Japan have shifted towards convenience and accessibility when it comes to healthcare services. With an aging population and an increasing demand for healthcare products, customers are seeking easily accessible pharmacies that offer a wide range of products and services. Pharmacies in Japan have responded to this demand by expanding their offerings to include not only prescription drugs, but also over-the-counter medications, health supplements, and beauty products. This customer-centric approach has attracted a large customer base and contributed to the growth of the Pharmacies market. Trends in the market indicate a growing emphasis on preventive healthcare and wellness. Customers in Japan are increasingly interested in maintaining their health and preventing illnesses through the use of supplements and natural remedies. This trend has led to an increase in the availability of alternative medicine products in pharmacies, catering to the evolving preferences of customers. Additionally, pharmacies are offering services such as health consultations and health screenings to provide a holistic approach to healthcare. Local special circumstances in Japan have also influenced the development of the Pharmacies market. The country's aging population has resulted in a higher demand for healthcare products and services. As the elderly population grows, pharmacies have adapted to cater to their specific needs, such as providing specialized products for age-related conditions and offering home delivery services. Furthermore, the prevalence of chronic diseases in Japan has led to an increased demand for medications, creating opportunities for pharmacies to expand their product offerings and services. Underlying macroeconomic factors have played a significant role in shaping the Pharmacies market in Japan. The country's robust economy and high disposable income levels have allowed customers to prioritize their health and spend more on healthcare products. Additionally, the government's focus on healthcare and wellness initiatives has created a favorable environment for the growth of the Pharmacies market. The implementation of policies that promote preventive healthcare and provide incentives for pharmacies to offer a wider range of services has further contributed to the development of the market. In conclusion, the Pharmacies market in Japan is developing in response to customer preferences for convenience and accessibility, along with the country's unique local special circumstances. The emphasis on preventive healthcare and wellness, the aging population, and the prevalence of chronic diseases have all contributed to the growth of the market. Additionally, underlying macroeconomic factors such as the country's robust economy and government initiatives have played a significant role in shaping the trends observed in the Pharmacies market in Japan.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.